[EN] IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS<br/>[FR] COMPOSES D'IMIDAZOLIDINE ET LEUR UTILISATION COMME ANTAGONISTES DE CXCR3
申请人:MILLENNIUM PHARM INC
公开号:WO2002085861A1
公开(公告)日:2002-10-31
Disclosed are novel compounds and a method of treating inflammatory diseases. The method comprises administering to an individual in need an effective amount of an imidazolidine compound represented by Structural Formula (1): and physiologically of pharmaceutically acceptable salts thereof.